Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 24;107(3):477-81.
doi: 10.1038/bjc.2012.268. Epub 2012 Jun 26.

Fetal haemopoiesis marking low-grade urinary bladder cancer

M Wolk  1 , J E Martin
Affiliations

Fetal haemopoiesis marking low-grade urinary bladder cancer

M Wolk et al. Br J Cancer. .

Abstract

Background: The immunohistochemical features of fetal haemoglobin cells and their distribution patterns in solid tumours, such as colorectal cancer and blastomas, suggest that fetal haemopoiesis may take place in these tumour tissues. These locally highly concentrated fetal haemoglobin (HbF) cells may promote tumour growth by providing a more efficient oxygen supply.

Methods and results: Biomarkers of HbF were checked in transitional cell carcinoma (TCC) of the urinary bladder, assessing this as a new parameter for disease management. Fetal haemoglobin was immunohistochemically examined in tumours from 60 patients with TCC of the bladder. Fetal haemoglobin erythrocytes and erythroblasts were mainly clonally distributed in proliferating blood vessels and not mixed with normal haemoglobin erythrocytes. The proportion of such HbF blood vessels could reach more than half of the total number of vessels. There were often many HbF erythroblasts distributed in one-cell or two-cell capillaries and present as 5-15% of cells in multi-cell vessels. This suggests a local proliferation of HbF-cell progenitors. Fetal haemoglobin cells were prominently marking lower grades of tumours, as 76% (n=21) of the patients with G1pTa were HbF+, whereas only 6.7% (n=30) of the patients with G3pT1-pT2a were HbF+.

Conclusion: Our results suggest that HbF, besides being a potential new marker for early tumour detection, might be an essential factor of early tumour development, as in fetal life. Inhibiting HbF upregulation may provide a therapeutic target for the inhibition of tumour growth.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Stages in proliferation of blood vessels with HbF cells in lamina propria of G1 TCC. Arrows indicating nucleated HbF progenitor cells: (A) clusters of HbF cells forming into fine vessels with many foci of nucleated HbF progenitor cells. (B) High density of small proliferating blood vessels. (C) Larger blood vessels spreading throughout the lamina propria.
Figure 2
Figure 2
Small capillary with two HbF erythroblasts.
Figure 3
Figure 3
Fetal haemoglobin cells, including nucleated (dark) cells, within tumour cells of G1 TCC.
Figure 4
Figure 4
Fetal haemoglobin cells including nucleated (dark) cells, within tumour cells of G2 TCC.
Figure 5
Figure 5
G3 TCC tumor with proliferating blood vessels (arrows) filled with normal Hb blood cells.
See this image and copyright information in PMC

References

    1. Bhnu NV, Trice TA, Lee YT, Miller JL (2004) A signaling mechanism for growth-related expression of fetal hemoglobin. Blood 103: 1929–1933 - PubMed
    1. Carlson BM (1988) The development of the circulatory system. In Patten's Foundations of Embryology, Dolinger E, Maisel J (eds). pp 594. McGraw-Hill: New York
    1. Fyrberg A, Peterson C, Kagedal B, Lotfi K (2011) Induction of fetal hemoglobin and ABCB1 gene exspression in 9-β-D-arabinofuranosylguanine-resistant MOLT-4 cells. Cancer Chemother Pharmacol 68: 583–591 - PubMed
    1. Gabbianelli M, Testa U, Morsilli O, Pelosi E, Saulle E, Petrucci E, Casteli G, Giovinazzi S, Mariani G, Fiori ME, Bonanno G, Massa A, Corce CM, Fontana L, Peschele C (2010) Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica 95: 1253–1260 - PMC - PubMed
    1. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 9: 1071–1121 - PMC - PubMed

MeSH terms